Abstract
1 The pharmacokinetics of a single intravenous dose of theophylline alone and during the fifth day of treatment with 500 mg erythromycin every 8 h was studied in six healthy subjects. 2 At the same time the pharmacokinetics of erythromycin at steady-state on the fourth day of the treatment (alone) and the fifth day (during the theophylline co-administration) were also studied. 3 Mean +/- s.d. theophylline clearance was decreased from 62 +/- 15.4 to 53 +/- 10.3 ml min-1 (P less than 0.05) and elimination half-life rose from 7.1 +/- 1.9 to 7.7 +/- 2 h (P less than 0.05) when erythromycin was co-administered. 4 Mean +/- s.d. erythromycin area under the curves (0-8 h) and (0-oc) were reduced from 6.09 +/- 3.2 to 3.8 +/- 2.5 micrograms ml-1 h and 7.2 +/- 3.6 to 5.0 +/- 2.9 micrograms ml-1 h (P less than 0.05) in the presence of theophylline. Mean steady state and maximum steady state concentrations were also reduced from 0.75 +/- 0.4 to 0.47 +/- 0.3 microgram ml-1 (P less than 0.05) and 1.45 +/- 0.87 to 0.85 +/- 0.51 microgram ml-1 (P less than 0.05) respectively. 5 The potential clinical implications of this indication should be considered.
Full text
PDF




Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Branigan T. A., Robbins R. A., Cady W. J., Nickols J. G., Ueda C. T. The effects of erythromycin on the absorption and disposition of kinetics of theophylline. Eur J Clin Pharmacol. 1981;21(2):115–120. doi: 10.1007/BF00637511. [DOI] [PubMed] [Google Scholar]
- Conrad K. A., Nyman D. W. Effects of metoprolol and propranolol on theophylline elimination. Clin Pharmacol Ther. 1980 Oct;28(4):463–467. doi: 10.1038/clpt.1980.189. [DOI] [PubMed] [Google Scholar]
- Debas H. T., Cohen M. M., Holubitsky I. B., Harrison R. C. Caffeine-stimulated acid and pepsin secretion: dose-response studies. Scand J Gastroenterol. 1971;6(5):453–457. doi: 10.3109/00365527109180725. [DOI] [PubMed] [Google Scholar]
- Hemsworth T. C., Renton K. W. Depression of theophylline metabolism and elimination by troleandomycin and erythromycin. Biochem Pharmacol. 1981 Jun 1;30(11):1299–1304. doi: 10.1016/0006-2952(81)90313-0. [DOI] [PubMed] [Google Scholar]
- Hunt S. N., Jusko W. J., Yurchak A. M. Effect of smoking on theophylline disposition. Clin Pharmacol Ther. 1976 May;19(5 Pt 1):546–551. doi: 10.1002/cpt1976195part1546. [DOI] [PubMed] [Google Scholar]
- Iliopoulou A., Thin R. N., Turner P. Fluorimetric and microbiological assays of erythromycin concentrations in plasma and vaginal washings. Br J Vener Dis. 1981 Aug;57(4):263–267. doi: 10.1136/sti.57.4.263. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lohmann S. M., Miech R. P. Theophylline metabolism by the rat liver microsomal system. J Pharmacol Exp Ther. 1976 Jan;196(1):213–225. [PubMed] [Google Scholar]
- Manfredi R. L., Vesell E. S. Inhibition of theophylline metabolism by long-term allopurinol administration. Clin Pharmacol Ther. 1981 Feb;29(2):224–229. doi: 10.1038/clpt.1981.36. [DOI] [PubMed] [Google Scholar]
- May D. C., Jarboe C. H., Ellenburg D. T., Roe E. J., Karibo J. The effects of erythromycin on theophylline elimination in normal males. J Clin Pharmacol. 1982 Feb-Mar;22(2-3):125–130. doi: 10.1002/j.1552-4604.1982.tb02659.x. [DOI] [PubMed] [Google Scholar]
- Pfeifer H. J., Greenblatt D. J., Friedman P. Effects of three antibiotics on theophylline kinetics. Clin Pharmacol Ther. 1979 Jul;26(1):36–40. doi: 10.1002/cpt197926136. [DOI] [PubMed] [Google Scholar]
- Renton K. W., Gray J. D., Hung O. R. Depression of theophylline elimination by erythromycin. Clin Pharmacol Ther. 1981 Sep;30(3):422–426. doi: 10.1038/clpt.1981.182. [DOI] [PubMed] [Google Scholar]
- Roberts R. K., Grice J., Wood L., Petroff V., McGuffie C. Cimetidine impairs the elimination of theophylline and antipyrine. Gastroenterology. 1981 Jul;81(1):19–21. [PubMed] [Google Scholar]
- Weinberger M., Hudgel D., Spector S., Chidsey C. Inhibition of theophylline clearance by troleandomycin. J Allergy Clin Immunol. 1977 Mar;59(3):228–231. doi: 10.1016/0091-6749(77)90154-3. [DOI] [PubMed] [Google Scholar]